Exhibit 5.1
![LOGO](https://capedge.com/proxy/8-K/0001193125-21-292090/g208316sp0051.jpg)
Writer’s Direct Dial: +1 212 225 2530
E-Mail: flodell@cgsh.com
October 5, 2021
American Tower Corporation
116 Huntington Avenue
Boston, Massachusetts 02116
Ladies and Gentlemen:
We have acted as special counsel to American Tower Corporation, a Delaware corporation (the “Company”), in connection with its offering pursuant to a registration statement on Form S-3 (No. 333-231931), as amended as of its most recent effective date (September 29, 2021), insofar as it relates to the Securities (as defined below) (as determined for purposes of Rule 430B(f)(2) under the Securities Act of 1933, as amended (the “Securities Act”)) (as so amended, including the documents incorporated by reference therein but excluding Exhibit 25, the “Registration Statement”) and the prospectus, dated June 4, 2019 (the “Base Prospectus”), as supplemented by the prospectus supplement thereto, dated September 29, 2021 (the “Prospectus Supplement” and, together with the Base Prospectus, the “Prospectus”), of €500,000,000 aggregate principal amount of its 0.400% Senior Notes due 2027 (the “2027 Notes”) and €500,000,000 aggregate principal amount of its 0.950% Senior Notes due 2030 (the “2030 Notes” and, together with the 2027 Notes, the “Securities”). The Securities were issued under an indenture dated as of June 4, 2019 (the “Base Indenture”) between the Company and U.S. Bank National Association, as trustee (the “Trustee”), as supplemented with respect to the Securities by Supplemental Indenture No. 11 thereto dated as of October 5, 2021 (the “Supplemental Indenture,” and together with the Base Indenture, the “Indenture”) between the Company, the Trustee and Elavon Financial Services DAC, UK Branch, as paying agent.
In arriving at the opinion expressed below, we have reviewed the following documents:
| (a) | the Registration Statement; |
Cleary Gottlieb Steen & Hamilton LLP or an affiliated entity has an office in each of the cities listed above.